Christophe Piketty

11PUBLICATIONS
29CO-AUTHORS
Peripheral nervous systemAllergyAdolescent healthDisease surveillancePacific Peoples cultural determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 17, 2025
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.

Franz J Legat, Shawn G Kwatra, Adam Reich

|Dec 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.

Sonja Ständer, Sarina B Elmariah, Shawn G Kwatra

|Dec 04, 2025
Response to Letter to the Editor from Dr. Paul et al.

Jonathan I Silverberg, Liliana Ulianov, Christophe Piketty

|Oct 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

Matthias Augustin, Marie Tauber, Robert Sidbury

|Apr 23, 2025
Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis.

Sonja Ständer, Danielle N Rodriguez, Carla Dias-Barbosa

|Mar 21, 2025
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis.

Jonathan I Silverberg, Danielle N Rodriguez, Carla Dias-Barbosa

Pageof 2